(Q73495329)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695729%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

IFN-beta modulates specific T cell responses in vitro but does not affect Experimental Autoimmune Encephalomyelitis in the SJL mouse (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695729%20AND%20SRC:MED&resulttype=core&format=json

experimental autoimmune encephalomyelitis

4 November 2019

main subject

1 reference

M E Luca

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695729%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L Visser

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695729%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C J Lucas

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695729%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L Nagelkerken

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695729%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695729%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695729%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695729%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695729%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

190-196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695729%20AND%20SRC:MED&resulttype=core&format=json

Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Role of trehalose dimycolate-induced interferon-alpha/beta in the restriction of encephalomyocarditis virus growth in vivo and in peritoneal macrophage cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Interferon-gamma confers resistance to experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Human recombinant interferon-beta influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Recombinant Interferon-β blocks proliferation but enhances interleukin-10 secretion by activated human T-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Selective expression of an interleukin-12 receptor component by human T helper 1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

IL-12 unmasks latent autoimmune disease in resistant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease prom

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Structure and characterization of a murine chromosomal fragment containing the interferon beta gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900198-8

7 January 2021

10.1016/S0165-5728(99)00198-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695729%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference